ATC Group: D01AE15 Terbinafine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D01AE15 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D01 Antifungals for dermatological use
3 D01A Antifungals for topical use
4 D01AE Other antifungals for topical use
5 D01AE15 Terbinafine

Active ingredients in D01AE15

Active Ingredient Description
Terbinafine

Terbinafine is an allylamine which has a broad spectrum of antifungal activity. Terbinafine acts by inhibition of squalene epoxidase in the fungal cell membrane. At low concentrations terbinafine is fungicidal against dermatophytes, moulds and certain dimorphic fungi. The activity versus yeasts is fungicidal or fungistatic depending on the species.

Related product monographs

Title Information Source Document Type  
LAMISIL Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
TERBINAFINE ACCORD Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
TERBINAFINE MYLAN Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Albania (AL)

Australia (AU)

Austria (AT)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Singapore (SG)

Spain (ES)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.